Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:837570rdf:typepubmed:Citationlld:pubmed
pubmed-article:837570lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:837570lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:837570lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:837570lifeskim:mentionsumls-concept:C0040676lld:lifeskim
pubmed-article:837570lifeskim:mentionsumls-concept:C0242960lld:lifeskim
pubmed-article:837570pubmed:issue3lld:pubmed
pubmed-article:837570pubmed:dateCreated1977-4-28lld:pubmed
pubmed-article:837570pubmed:abstractTextIncorporation of hypoxanthine, resistance to 8-azaguanine and activation by lyophilisation have been studied in cultured human fibroblasts. Cells from one family where there was a boy with Lesch-Nyham syndrome, from two families with variant H-PRT mutations and three cell strains from patients with the Lesch-Nyham syndrome were investigated. Cells from patients with the Lesch-Nyham syndrome showed almost no hypoxanthine incorporation and resistance to concentrations of 8-azaguanine up to 10(-3) M, whereas cells of patients with partial H-PRT deficiency demonstrated variant patterns of hypoxanthine uptake and partial resistance to 8-azaguanine. Lyophilisation of fibroblast sediment from patients with the Lesch-Nyhan syndrome and patients with variant H-PRT mutations showed activation of the deficient or partially deficient H-PRT enzyme. No such activation was observed in healthy controls. Activation of lyophilised fibroblast extract from patients and controls was not obtained. These results suggest that H-PRT could be associated with the cell membranes.lld:pubmed
pubmed-article:837570pubmed:languageenglld:pubmed
pubmed-article:837570pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:837570pubmed:citationSubsetIMlld:pubmed
pubmed-article:837570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:837570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:837570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:837570pubmed:statusMEDLINElld:pubmed
pubmed-article:837570pubmed:monthMarlld:pubmed
pubmed-article:837570pubmed:issn0009-9163lld:pubmed
pubmed-article:837570pubmed:authorpubmed-author:SinghSSlld:pubmed
pubmed-article:837570pubmed:authorpubmed-author:HeldK RKRlld:pubmed
pubmed-article:837570pubmed:authorpubmed-author:GoeddeH WHWlld:pubmed
pubmed-article:837570pubmed:authorpubmed-author:WillertHHlld:pubmed
pubmed-article:837570pubmed:issnTypePrintlld:pubmed
pubmed-article:837570pubmed:volume11lld:pubmed
pubmed-article:837570pubmed:ownerNLMlld:pubmed
pubmed-article:837570pubmed:authorsCompleteYlld:pubmed
pubmed-article:837570pubmed:pagination193-200lld:pubmed
pubmed-article:837570pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-H...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-H...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-M...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-F...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-M...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-F...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-F...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-C...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-A...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-H...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-L...lld:pubmed
pubmed-article:837570pubmed:meshHeadingpubmed-meshheading:837570-H...lld:pubmed
pubmed-article:837570pubmed:year1977lld:pubmed
pubmed-article:837570pubmed:articleTitleGenetic heterogeneity of hypoxanthine-phosphoribosyl transferase in human fibroblasts of 3 families.lld:pubmed
pubmed-article:837570pubmed:publicationTypeJournal Articlelld:pubmed